M J Calves

1.5k total citations
11 papers, 1.3k citations indexed

About

M J Calves is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, M J Calves has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Immunology. Recurrent topics in M J Calves's work include Glycosylation and Glycoproteins Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (8 papers). M J Calves is often cited by papers focused on Glycosylation and Glycoproteins Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (8 papers). M J Calves collaborates with scholars based in United States. M J Calves's co-authors include Friedhelm Helling, Philip O. Livingston, Gerd Ritter, P O Livingston, Lloyd J. Old, Sucharita Adluri, Herbert F. Oettgen, Edward J. Natoli, Tao Yue and Gabriel Wong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

M J Calves

11 papers receiving 1.2k citations

Peers

M J Calves

IMMUN

MB

RNMI

ONCOL

OC

P O Livingston United States

Jerry Liao United States

Adriana Carr Cuba

Yasuo Fukushi Japan

Lori O'Connell United States

Gianfranco Picco United Kingdom

Mehmet Kemal Tur Germany

K Zenita Japan

Royston Jefferis United Kingdom

Hanspeter Amstutz Switzerland

P O Livingston United States

M J Calves

453 ×0.5

IMMUN

536 ×0.6

MB

339 ×0.7

RNMI

130 ×0.3

ONCOL

112 ×0.5

OC

Citations per year, relative to M J Calves M J Calves (= 1×) peers P O Livingston

Countries citing papers authored by M J Calves

Since Specialization

Citations

This map shows the geographic impact of M J Calves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J Calves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J Calves more than expected).

Fields of papers citing papers by M J Calves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J Calves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J Calves. The network helps show where M J Calves may publish in the future.

Co-authorship network of co-authors of M J Calves

This figure shows the co-authorship network connecting the top 25 collaborators of M J Calves. A scholar is included among the top collaborators of M J Calves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J Calves. M J Calves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ritter, Gerd, M J Calves, Shunlin Ren, et al.. (1995). Analysis of the antibody response to immunization with purified O‐acetyl GD3 gangliosides in patients with malignant melanoma. International Journal of Cancer. 62(6). 668–672. 34 indexed citations

2.

Helling, Friedhelm, Shengle Zhang, Sucharita Adluri, et al.. (1995). GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.. PubMed. 55(13). 2783–8. 171 indexed citations

3.

Livingston, Philip O., Gabriel Wong, Sucharita Adluri, et al.. (1994). Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.. Journal of Clinical Oncology. 12(5). 1036–1044. 419 indexed citations

4.

Helling, Friedhelm, M J Calves, Shengle Zhang, et al.. (1994). GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.. PubMed. 54(1). 197–203. 155 indexed citations

5.

Livingston, Philip O., M J Calves, Friedhelm Helling, et al.. (1993). GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3. Vaccine. 11(12). 1199–1204. 38 indexed citations

6.

Helling, Friedhelm, et al.. (1993). Construction of Immunogenic GD3‐Conjugate Vaccines. Annals of the New York Academy of Sciences. 690(1). 396–397. 4 indexed citations

7.

Ritter, Gerd, et al.. (1991). Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. International Journal of Cancer. 48(3). 379–385. 63 indexed citations

8.

Ritter, Gerd, et al.. (1990). Antibody Response to Immunization with Purified GD3 Ganglioside and GD3 Derivatives (Lactones, Amide and Gangliosidol) in the Mouse. Immunobiology. 182(1). 32–43. 30 indexed citations

9.

Livingston, Philip O., et al.. (1989). Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.. PubMed. 49(24 Pt 1). 7045–50. 105 indexed citations

10.

Livingston, P O, M J Calves, & Edward J. Natoli. (1987). Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.. The Journal of Immunology. 138(5). 1524–1529. 54 indexed citations

11.

Livingston, P O, Edward J. Natoli, M J Calves, et al.. (1987). Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.. Proceedings of the National Academy of Sciences. 84(9). 2911–2915. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact